BioBurst Fluid

Burst Biologics Initiates Prospective Multicenter Clinical Study in Spinal Fusion

March 28, 2017 BOISE, Idaho–(BUSINESS WIRE)–Burst Biologics has received IRB approval to begin a multicenter prospective clinical study in spinal…